FDA Grants Accelerated Approval To Encorafenib With Cetuximab And MFOLFOX6 For Metastatic Colorectal Cancer With A BRAF V600E Mutation

Benzinga12/21 02:20

Franklin Resources Analyst Ratings

Benzinga12/21 02:07

UBS Maintains Neutral on Verizon Communications, Raises Price Target to $45

Benzinga12/20 22:41

Verizon Communications Analyst Ratings

Benzinga12/20 22:40

Lumen Wireline Assets May Be Worth $7B-$10B in a Sale - Analyst

Seeking Alpha12/20 04:05

Your Healthcare Costs Are Soaring! US Spending Reached $5 Trillion In 2023 With Major Increase in Obesity and Diabetes Drugs, Hospital Services

Benzinga12/20 02:38